PAI1 (SERPINE1) Mouse Monoclonal Antibody [Clone ID: MA-33H1F7]

CAT#: AM32111PU-N

PAI1 (SERPINE1) mouse monoclonal antibody, clone MA-33H1F7, Liquid



Need it in bulk or conjugated?
Get a free quote

CNY 8,475.00


货期*
5周

规格
    • 1 ml

Product images

Specifications

Product Data
Clone Name MA-33H1F7
Applications ELISA, FN, IHC, WB
Recommend Dilution Western blotting. 
Immuno Assays.
Immunohistochemistry on Frozen Sections. 
Inhibition: For inhibition of biological activity dilutions have to be made according to the amounts PAI-1 to be inactivated.
Reactivity Human, Mouse, Rabbit, Rat
Host Mouse
Clonality Monoclonal
Specificity

The epitope of Monoclonal antibody MA-33H1F7 is predominantly composed of three residues (Lys154/Glu130/Arg131), positioned virtually linearly in the three-dimensional structure.
The epitope of the antibody does not cover the complete alpha-helix F and turn connecting alpha-helix F and beta-strand s3A, but is restricted to the hinge region between alpha-helix F and the main part of the PAI-1 molecule.
The Monoclonal antibody MA-33H1F7 is a switching antibody, capable of inducing a non-inhibitory substrate form of PAI-1.

Formulation PBS
State: Liquid
State: Liquid 0.2 µm filtered
Stabilizer: 0.1% BSA
Preservative: 0.02% Sodium Azide
Concentration lot specific
Conjugation Unconjugated
Storage Condition Store the antibody undiluted at 2-8°C. 
Gene Name serpin family E member 1
Background Plasminogen activator inhibitor type-1 (PAI-1), a member of the serine protease inhibitor (serpin) superfamily is an important protein in the regulation of fibrinolysis. PAI-1 is unique among the serpins because of its functional and conformational flexibility. PAI-1 is the most important physiological inhibitor of both tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA). Increased PAI-1 levels are associated with thrombotic events and is an established risk factor for cardiovascular diseases. The active conformation PAI-1 inhibits its target proteinases by the formation of a stable, inactive complex. Although PAI-1 is synthesized as an active molecule, it converts spontaneously to an inactive, latent form that can be partially reactivated by denaturing agents. In addition, a third conformation reacting as a non-inhibitory substrate towards various target proteinases has been identified.
Synonyms Serpin E1, PLANH1, Plasminogen Activator Inhibitor 1, PAI-1, PAI
Reference Data
Protein Families Druggable Genome, Secreted Protein
Protein Pathways Complement and coagulation cascades, p53 signaling pathway
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...